Afelimomab
Afelimomab (MAK 195F) is an anti-tumor necrosis factor monoclonal antibody. Afelimomab can be used for the research of sepsis[1].
Product Specifications
CAS Number
156227-98-4
Product Name Alternative
MAK 195F
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/afelimomab.html
Purity
99.34
Solubility
10 mM in DMSO
Smiles
[Afelimomab]
Molecular Weight
(145.82 kDa)
References & Citations
[1]Edward A Panacek, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F (ab') 2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004 Nov;32 (11) :2173-82.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-12544R-PE-Cy7 100 µL
ATIC/PURH Polyclonal Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details MBS4381673-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
Apolipoprotein A4/apoA-IV
Sign In for Pricing
View Details MBS4381673-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
Apolipoprotein A4/apoA-IV
Sign In for Pricing
View Details MBS4381673-03 0.1 mg (Without BSA & Azide at 1mg/mL)
Apolipoprotein A4/apoA-IV
Sign In for Pricing
View Details